Hematologic Oncology Update cover art

Hematologic Oncology Update

Hematologic Oncology Update

By: Dr. Neil Love
Listen for free

About this listen

Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.Copyright 2025 Research To Practice. All Rights Reserved Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
    Apr 20 2026

    Dr Amir Fathi from Massachusetts General Hospital in Boston, Massachusetts, and Dr Eunice S Wang from Roswell Park Comprehensive Cancer Center in Buffalo, New York, discuss key clinical trial data surrounding the use of menin inhibitors in the management of AML.

    CME information and select publications here.

    Show More Show Less
    59 mins
  • CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson
    Apr 10 2026

    Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.

    CME information and select publications here.

    Show More Show Less
    25 mins
  • Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review
    Apr 1 2026

    Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia.

    CME information and select publications here.

    Show More Show Less
    25 mins
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.